Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
health decrease » deaths decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
health decrease » deaths decreased (Expand Search)
-
1521
-
1522
-
1523
-
1524
-
1525
Supplementary Material for: Allopurinol Use is Associated With Decreased Incidence of Hepatic Decompensation and Overall Mortality Among Individuals With Cirrhosis: a Propensity-ma...
Published 2025“…Background: Cirrhosis is associated with significant morbidity and mortality. Recent studies have highlighted the potential role of allopurinol in reducing the incidence of hepatic decompensation among individuals with cirrhosis. …”
-
1526
-
1527
Number of visits per clinic type, 2013-2015.
Published 2025“…During PE, statistically significant longer waiting times were found for surgery (+1.0 day) and imaging (+1.1 days), while a 2.4 days decrease was noted in pediatrics, controlled for age, sex, ethnicity and the daily number of visits. …”
-
1528
Table 1_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls
Published 2025“…</p>Conclusion<p>Our findings indicate that α-conotoxin [D1G, ΔQ14] LvIC significantly decreased locomotor activity in mice. Additionally, it altered gene expression primarily in areas related to neuronal development, synapse formation, and neuron activity, while also reducing synapse strength. …”
-
1529
Table 2_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls
Published 2025“…</p>Conclusion<p>Our findings indicate that α-conotoxin [D1G, ΔQ14] LvIC significantly decreased locomotor activity in mice. Additionally, it altered gene expression primarily in areas related to neuronal development, synapse formation, and neuron activity, while also reducing synapse strength. …”
-
1530
-
1531
-
1532
Signal strength of reports of finasteride administration at the PT level (age < 18).
Published 2025Subjects: -
1533
-
1534
-
1535
-
1536
Time to onset of AEs in male and female patients receiving finasteride therapy.
Published 2025Subjects: -
1537
-
1538
-
1539
Signal strength of reports of finasteride administration in female at the PT level.
Published 2025Subjects: -
1540
Signal strength of reports of finasteride administration in male at the PT level.
Published 2025Subjects: